Trials / Completed
CompletedNCT02795780
Follow up 18F-AV-1451 Scan in Confirmatory Cohort Subjects From Study 18F-AV-1451-A05
An Open Label, Multicenter Study Evaluating the Imaging Characteristics of a Follow up 18F-AV-1451 Scan in Subjects That Participated in the Confirmatory Cohort of 18F-AV-1451-A05
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 79 (actual)
- Sponsor
- Avid Radiopharmaceuticals · Industry
- Sex
- All
- Age
- 50 Years
- Healthy volunteers
- Not accepted
Summary
This study will evaluate longitudinal change of tau deposition as measured by flortaucipir F 18 uptake over time.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Flortaucipir F18 | 370 megabecquerel (MBq) IV single-dose |
| PROCEDURE | PET Scan | positron emission tomography (PET) scan |
Timeline
- Start date
- 2016-08-01
- Primary completion
- 2017-08-28
- Completion
- 2017-08-28
- First posted
- 2016-06-10
- Last updated
- 2020-08-24
- Results posted
- 2020-08-24
Locations
22 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT02795780. Inclusion in this directory is not an endorsement.